Skip to content
Broker news. Connected. RSS feed
FXBROKERS

A clearer view of the broker industry.

Injective and BDACS plan won settlement for tokenised assets

Their memorandum targets institutional use of KRW1 on Injective. The issuer’s redemption model makes access to bank money a separate part of the settlement process.

Injective and BDACS have signed a memorandum of understanding to develop KRW1 settlement for tokenised assets on Injective. The 20 October announcement targets Korean institutions and makes access to minting and redemption conditional on regulatory approval.[1]

The commercial aim is to let won-denominated assets trade and settle without routing payment through a dollar stablecoin. The companies plan to work with Korean financial institutions on issuance and will announce further developments as individual uses enter service.[1]

From a token balance to a bank balance

BDACS’s KRW1 whitepaper distinguishes circulation from direct redemption. Issuance and redemption require onboarding with BDACS, identity and anti-money-laundering checks, and an approved wallet. Fiat proceeds go to a bank account registered in advance. Holding tokens alone therefore does not confer direct access to the issuer’s redemption channel.[2]

Fiat minting and redemption follow banking business days, cut-offs and holidays. The whitepaper says proceeds are generally remitted within one banking business day, with same-day processing before the applicable cut-off. Fees depend on the client agreement.[2]

For a trading firm operating outside bank hours, moving tokens and replenishing a won bank balance remain separate operations. Won settlement can reduce a conversion step; any underlying asset’s foreign-currency exposure still depends on what that instrument represents.[1][2]

Follow the evidence

Sources & further reading

  1. KRW1 Whitepaper BDACS · Accessed 21 Oct 2026

Report an error or submit an update